Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helvig, C.
Right arrow Articles by Salaün, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helvig, C.
Right arrow Articles by Salaün, J.-P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 1, Issue of January 3, 1997 pp. 414-421
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Suicide Inactivation of Cytochrome P450 by Midchain and Terminal Acetylenes
A MECHANISTIC STUDY OF INACTIVATION OF A PLANT LAURIC ACID omega -HYDROXLYASE

(Received for publication, May 25, 1996, and in revised form, October 9, 1996)

Christian Helvig Dagger , Carole Alayrac , Charles Mioskowski , Dennis Koop ** , Didier Poullain Dagger Dagger , Francis Durst Dagger and Jean-Pierre Salaün Dagger

From the Dagger  Institut de Biologie Moléculaire des Plantes-CNRS, Département d'Enzymologie Cellulaire et Moléculaire, 28 rue Goethe, F-67083 Strasbourg Cedex, France,  CNRS-URA 1386 Faculté de Pharmacie, Laboratoire de Synthèse Bio-Organique, 74 route du Rhin, F-67048 Strasbourg Cedex, France, ** Department of Pharmacology, School of Medicine, Oregon Health Sciences University, Portland, Oregon 97201-3098, and Dagger Dagger  Commissariat à l'Energie Atomique, Service des Molécules Marquées, F-91191 Gif-sur-Yvette Cedex, France

Incubation of Vicia sativa microsomes, containing cytochrome P450-dependent lauric acid omega -hydroxylase (omega -LAH), with [1-14C]11-dodecynoic acid (11-DDYA) generates a major metabolite characterized as 1,12-dodecandioic acid. In addition to time- and concentration-dependent inactivation of lauric acid and 11-DDYA oxidation, irreversible binding of 11-DDYA (200 pmol of 11-DDYA bound/mg of microsomal protein) at a saturating concentration of 11-DDYA was observed. SDS-polyacrylamide gel electrophoresis analysis showed that 30% of the label was associated with several protein bands of about 53 kDa. The presence of beta -mercaptoethanol in the incubate reduces 1,12-dodecandioic acid formation and leads to a polar metabolite resulting from the interaction of oxidized 11-DDYA with the nucleophile. Although the alkylation of proteins was reduced, the lauric acid omega -hydroxylase activity was not restored, suggesting an active site-directed inactivation mechanism. Similar results were obtained when reconstituted mixtures of cytochrome P450 from family CYP4A from rabbit liver were incubated with 11-DDYA. In contrast, both 11- and 10-DDYA resulted in covalent labeling of the cytochrome P450 2B4 protein and irreversible inhibition of activity. These results demonstrate that acetylenic analogues of substrate are efficient mechanism-based inhibitors and that a correlation between the position of the acetylenic bond in the inhibitor and the regiochemistry of cytochromes P450 oxygenation is essential for enzyme inactivation.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H.-l. Lin, H. Zhang, and P. F. Hollenberg
Metabolic Activation of Mifepristone [RU486; 17{beta}-Hydroxy-11{beta}-(4-dimethylaminophenyl)-17{alpha}-(1-propynyl)-estra-4,9-dien-3-one] by Mammalian Cytochromes P450 and the Mechanism-Based Inactivation of Human CYP2B6
J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 26 - 37.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. L. Boshans, S. Szanto, L. van Aelst, and C. D'Souza-Schorey
ADP-Ribosylation Factor 6 Regulates Actin Cytoskeleton Remodeling in Coordination with Rac1 and RhoA
Mol. Cell. Biol., May 15, 2000; 20(10): 3685 - 3694.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
K. He, T. F. Woolf, and P. F. Hollenberg
Mechanism-Based Inactivation of Cytochrome P-450-3A4 by Mifepristone (RU486)
J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 791 - 797.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
F. Adas, F. Berthou, D. Picart, P. Lozac'h, F. Beaugé, and Y. Amet
Involvement of cytochrome P450 2E1 in the ({omega}–1)-hydroxylation of oleic acid in human and rat liver microsomes
J. Lipid Res., June 1, 1998; 39(6): 1210 - 1219.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M.-H. Wang, E. Brand-Schieber, B. A. Zand, X. Nguyen, J. R. Falck, N. Balu, and M. L. Schwartzman
Cytochrome P450-Derived Arachidonic Acid Metabolism in the Rat Kidney: Characterization of Selective Inhibitors
J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 966 - 973.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement